share_log

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga ·  May 7 12:31

Gainers

  • Nuwellis (NASDAQ:NUWE) shares rose 57.7% to $0.27 during Tuesday's regular session. The company's market cap stands at $4.1 million. As per the news, the Q1 earnings report came out today.
  • Bioventus (NASDAQ:BVS) stock moved upwards by 28.87% to $5.16. The market value of their outstanding shares is at $329.0 million. The company's, Q1 earnings came out today.
  • Design Therapeutics (NASDAQ:DSGN) stock rose 28.49% to $4.69. The market value of their outstanding shares is at $264.9 million.
  • Acutus Medical (NASDAQ:AFIB) stock moved upwards by 24.11% to $0.13. The company's market cap stands at $3.9 million.
  • Oragenics (AMEX:OGEN) shares moved upwards by 22.78% to $1.33. The market value of their outstanding shares is at $5.9 million.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) shares moved upwards by 22.61% to $1.2.

Losers

  • Neuronetics (NASDAQ:STIM) stock declined by 33.1% to $2.51 during Tuesday's regular session. The company's market cap stands at $75.2 million. As per the news, the Q1 earnings report came out today.
  • Helius Medical Tech (NASDAQ:HSDT) shares decreased by 25.62% to $1.8. The market value of their outstanding shares is at $1.5 million.
  • Allarity Therapeutics (NASDAQ:ALLR) stock declined by 20.08% to $0.72. The market value of their outstanding shares is at $1.7 million.
  • Lyra Therapeutics (NASDAQ:LYRA) stock fell 17.86% to $0.43. The market value of their outstanding shares is at $26.1 million.
  • GlucoTrack (NASDAQ:GCTK) stock decreased by 16.28% to $0.64. The market value of their outstanding shares is at $17.1 million.
  • Talkspace (NASDAQ:TALK) stock declined by 15.1% to $2.7. The company's market cap stands at $458.0 million. The company's, Q1 earnings came out today.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment